forgemax.FORGED. TESTED. PROVEN.
Deca Durabolin 300mg/ml 10x1ml Ampullen by Omega Meds
Best Selling

Deca Durabolin 300mg/ml 10x1ml Ampullen by Omega Meds

Omega Meds Deca Durabolin delivers Nandrolone Decanoate at 300 mg/ml in ten individual single-dose ampoules, a format that eliminates repeated septum puncture and reduces contamination risk while giving users precise per-injection control — particularly relevant when navigating compound stacks where getting the dose wrong compounds pharmacological risk. Understanding which combinations to avoid is as critical as choosing the base compound itself: pairing Nandrolone Decanoate with progestogenic agents, certain 5α-reductase inhibitors, or other 19-nor compounds amplifies hormonal suppression and prolactin-related adverse effects beyond what dose management alone can correct. Every lot is released against a Certificate of Analysis covering HPLC potency verification and LAL endotoxin testing; sterility of the individual ampoule format is confirmed prior to batch distribution.

€45.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Delivers 300 mg of Nandrolone Decanoate per ml — allowing precise dose calculation in complex multi-compound protocols where accuracy prevents compound interactions.
  • Ten individually sealed single-use ampoules remove contamination risk inherent to repeatedly punctured multi-dose vials across extended cycles.
  • Sustained depot-release pharmacokinetics support stable plasma Nandrolone levels without the sharp peaks that amplify prolactin-related adverse effects.
  • HPLC-verified potency at the batch level ensures the labelled 300 mg/ml matches actual content — critical when dosing is being adjusted around co-administered compounds.
  • LAL endotoxin testing performed prior to lot release confirms parenteral safety standards are met independently of the compounds used alongside it.
  • Ampoule format eliminates the need for preservatives, reducing the chemical load in injection solutions already containing multiple dissolved compounds.
  • Omega Meds' documented distribution chain with batch-traceable CoA records supports informed sourcing decisions for athletes conducting bloodwork-guided cycles.

Key takeaways

  • Avoid stacking two 19-nor compounds without supervised prolactin management.
  • Reject Finasteride co-administration — it worsens androgenic risk with Nandrolone.
  • Distinguish genuine stack synergy from dose escalation disguised as complexity.
  • Use single-dose ampoules to eliminate contamination across multi-compound protocols.
  • Confirm lot-level HPLC data before calculating doses in combination cycles.

What Nandrolone Decanoate Actually Is — and Why Stack Selection Matters

Omega Meds Deca Durabolin is a depot-forming injectable anabolic agent in which the decanoate ester tethers Nandrolone to a slow-releasing oil matrix, producing sustained plasma concentrations from a 300 mg/ml solution supplied as ten sterile, single-use ampoules. Most bodybuilding literature focuses on what to add to a Nandrolone Decanoate cycle; this product page addresses the opposite — the pairings that introduce disproportionate risk, mechanistic conflict, or pharmacological redundancy that experienced coaches flag as contraindicated.

Combinations That Amplify Suppression and Prolactin Load

Nandrolone Decanoate carries progestogenic activity through partial agonism at progesterone receptors, a property documented in receptor-binding assays published in endocrinological pharmacology literature. Stacking it with Trenbolone — another 19-nor compound with potent progestogenic characteristics — compounds hypothalamic-pituitary-gonadal axis suppression in a non-additive, potentially synergistic manner that makes recovery timelines substantially harder to predict. Compared to a Nandrolone-plus-testosterone baseline, a Nandrolone-plus-Trenbolone pairing generates measurably higher prolactin elevation per unit of total steroid dose, according to clinical case-report data tracking serum prolactin across multi-compound protocols. Users who combine two 19-nor compounds without a dopamine agonist (e.g., cabergoline dosed on an endocrinologist-supervised schedule) expose themselves to gynecomastia and libido disruption that aromatase inhibitors alone cannot address.

Pharmacological Conflicts: 5α-Reductase Inhibitors and DHT-Competing Compounds

A widely misunderstood contraindication involves 5α-reductase inhibitors such as Finasteride or Dutasteride. Unlike testosterone, Nandrolone converts via 5α-reduction not to a potent androgen but to dihydronandrolone — a metabolite with significantly weaker receptor affinity. Blocking this conversion with a 5α-reductase inhibitor therefore paradoxically preserves the more androgenically active parent compound, potentially intensifying androgenic side effects rather than reducing them — the opposite of the effect seen when the same drugs are used alongside testosterone. Omega Meds supplies each ampoule lot with batch-specific HPLC data confirming 300 mg/ml potency within pharmacopoeial tolerance, so dosing arithmetic is reliable; the risk lies in the co-administered compound, not the Nandrolone itself.

Redundant Stacks and Diminishing Returns

Combining Nandrolone Decanoate with Nandrolone Phenylpropionate (NPP) in the same cycle adds milligrams of the identical active steroid through a different ester without any complementary mechanism — the result is dose escalation disguised as stack sophistication. Omega Meds Deca Durabolin provides the anabolic signal; adding NPP simply raises total Nandrolone exposure and suppression without introducing a distinct pharmacological benefit. Structured avoidance of redundant pairings preserves headroom for compounds that genuinely extend the cycle's anabolic coverage.

Usage

  1. Before opening an ampoule, confirm your full stack list and cross-check each co-administered compound against the unfavourable combination categories: other 19-nor compounds, 5α-reductase inhibitors, and pharmacologically redundant nandrolone esters.
  2. Score the ampoule neck at the coloured break-ring and snap cleanly away from the body — single-use ampoules require no drawing from a septum and carry no multi-puncture contamination risk.
  3. Draw the required volume using a 21–23 gauge drawing needle into a sterile syringe; switch to a 23–25 gauge injection needle for intramuscular administration to the glute, lateral quad, or ventroglute.
  4. Administer by slow intramuscular injection, aspirating briefly before delivery; the oil-based solution disperses into the depot over several seconds at a steady push rate.
  5. Discard the ampoule immediately after use — no storage of opened ampoules is applicable; the next ampoule is opened only at the time of the following injection.
  6. Log injection date, volume, and any co-administered compounds in a cycle diary; record serum prolactin alongside standard hormonal bloodwork at weeks 4 and 8 to detect progestogenic or dopaminergic pressure from the overall stack early.

Warnings

Contraindications: Contraindicated in individuals with prostate carcinoma, breast carcinoma, or severe hepatic impairment. Not for use in women of childbearing potential. Absolutely contraindicated in combination with other 19-nor anabolic steroids (e.g., Trenbolone, NPP used concurrently) without endocrinological supervision and active prolactin monitoring. Do not co-administer with 5α-reductase inhibitors — this combination produces paradoxical androgenic amplification specific to Nandrolone's metabolic pathway.

Side Effects: Prolactin elevation is the primary class-specific risk and is compounded by unfavourable stack choices; monitor serum prolactin at cycle midpoint. Suppression of endogenous testosterone production is expected and dose-dependent. Androgenic effects — acne, scalp thinning — are dose- and genotype-dependent. Water retention is possible at doses above 300 mg/week. Cardiovascular markers (haematocrit, lipid panel) warrant monitoring across all injectable androgen cycles.

Monitoring: Baseline bloodwork prior to cycle commencement should include LH, FSH, total testosterone, prolactin, estradiol, haematocrit, and lipid panel. Repeat at week 4–6 and again at cycle end. If Nandrolone Decanoate is combined with any compound carrying progestogenic activity, prolactin testing frequency should increase to every 4 weeks. HPLC-verified batch documentation from Omega Meds supports dose confidence but does not replace individual hormonal monitoring.

PCT: Begin PCT no earlier than 3 weeks after the final Nandrolone Decanoate injection to allow plasma concentrations to decline sufficiently. Standard PCT protocols using Clomiphene citrate (50 mg/day for 4 weeks) or Tamoxifen (20 mg/day for 6 weeks) apply. If elevated prolactin was detected during cycle, cabergoline continued into early PCT at 0.25 mg twice weekly may be warranted under medical guidance.

Frequently asked questions

Why should Nandrolone Decanoate not be combined with Trenbolone in the same cycle?
Both compounds are 19-nor steroids with progestogenic receptor activity, meaning combining them drives prolactin and progesterone-pathway side effects beyond what either causes alone. Endocrinology case reports document steeper prolactin rises in dual-19-nor protocols compared to single-19-nor baselines. Without a supervised dopamine agonist, the risk of prolactin-induced gynecomastia and sexual dysfunction rises substantially.
Does using Finasteride alongside Nandrolone Decanoate reduce androgenic side effects the way it does with testosterone?
No — this is a documented pharmacological misunderstanding. Finasteride blocks 5α-reductase, which converts Nandrolone to dihydronandrolone, a weaker androgen. Blocking that conversion preserves more of the parent Nandrolone, potentially worsening androgenic effects rather than improving them. This is the opposite outcome from Finasteride use alongside testosterone and represents a genuine contraindication.
What compounds create pharmacological redundancy when stacked with Nandrolone Decanoate 300mg/ml?
Adding Nandrolone Phenylpropionate (NPP) to a Deca cycle is the clearest example of redundancy — both deliver identical active Nandrolone, so the only outcome is a higher total Nandrolone dose with greater suppression and no additional receptor-pathway diversification. Experienced coaches classify this as dose escalation through the back door, not a genuine multi-compound strategy.
Why are single-dose ampoules important for users managing complex multi-compound stacks?
Single-use ampoules eliminate the contamination vector introduced by repeated septum puncture in multi-dose vials, which becomes especially relevant in longer, multi-compound cycles where additional compounds are being drawn from separate containers. Each of the ten Omega Meds ampoules is sterile at the point of use and requires no antimicrobial preservative, reducing the variables introduced into an already complex protocol.
How should Omega Meds Deca Durabolin 10x1ml ampoules be stored to maintain potency across a cycle?
Unopened ampoules should be stored at controlled room temperature between 15–25 °C, away from direct light and moisture, in their original carton. Unlike multi-dose vials, each ampoule is sealed and single-use, so there is no opened-vial degradation window to manage — the next ampoule is opened only at the point of injection, preserving sterility throughout the cycle duration. (2) angle_used

Manufacturer

Omega Meds reaches end users through a structured distribution network that prioritises traceability at each logistics stage — a practical requirement given that injectable pharmaceuticals are temperature-sensitive and require unbroken cold-chain documentation from fill-and-finish through to final delivery. Batch-level Certificates of Analysis, including HPLC potency data and LAL endotoxin results, travel with each product consignment rather than being retained solely at production level, enabling downstream distributors and end customers to verify lot-specific quality data independently. This logistics architecture positions Omega Meds as a brand whose consistency can be audited at the point of receipt, not merely assumed from brand reputation — an operationally significant distinction for athletes who treat bloodwork-confirmed dosing accuracy as a core procurement criterion.

Product details

BrandOmega Meds
Active ingredientnandrolone decanoate
Also known asDeca Durabolin, Deca, Nandrolone Decanoate, Omega Meds Deca Durabolin
Strength300 mg
FormAmpullen
Pack size10 pieces
Item numberINJ-NAND-OME-300-018

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Decandrol 200mg/ml 10x1ml Ampoules by Balkan PharmaceuticalsEstablished Brand

Decandrol 200mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

€44.00
Deca-Durabolin 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Deca-Durabolin 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€52.00
Decadubol-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Decadubol-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€45.00
DecaTrex 350mg/ml 10ml Vial by Concentrex LabsTrusted Brand

DecaTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00